Davide Bonazzi
Illustrator
From this contributor
Company on brink takes psilocybin to trial for fragile X syndrome
The phase 2A trial has its detractors despite positive animal results and is being sponsored by a company that is struggling financially.
Company on brink takes psilocybin to trial for fragile X syndrome
Explore more from The Transmitter
In memoriam: Howard Fields, pain research pioneer
Over six decades, Fields mapped out the circuits of both pain and addiction.
In memoriam: Howard Fields, pain research pioneer
Over six decades, Fields mapped out the circuits of both pain and addiction.
Still no proof for facilitated spelling methods
A systematic review into whether the “rapid prompting method” or “spelling to communicate” can help autistic people express themselves comes up empty yet again.
Still no proof for facilitated spelling methods
A systematic review into whether the “rapid prompting method” or “spelling to communicate” can help autistic people express themselves comes up empty yet again.
Oregon primate center scientists fight proposed sanctuary transition
A group of employees has launched a series of campaigns to advocate for their work and argue against the center’s potential transition to an animal sanctuary.
Oregon primate center scientists fight proposed sanctuary transition
A group of employees has launched a series of campaigns to advocate for their work and argue against the center’s potential transition to an animal sanctuary.